Reduction in expression of the astrocyte glutamate transporter, GLT1, worsens functional and histological outcomes following traumatic spinal cord injury

GLIA

Volumn 59, Issue 12, 2011, Pages 1996-2005

  Lepore, Angelo C ^a,b   O'donnell, John ^c   Kim, Andrew S ^c   Yang, Eun Ju ^c   Tuteja, Alisha ^c   Haidet Phillips, Amanda ^c   O'Banion, Colin P ^c   Maragakis, Nicholas J ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crush injury; Excitotoxicity; GLT1+ mice; Glutamate uptake; Secondary injury

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE TRANSPORTER; GLUTAMATE TRANSPORTER GLT1; GLUTAMIC ACID; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL LOSS; CONTROLLED STUDY; CRUSH TRAUMA; GRAY MATTER; HINDLIMB; HISTOPATHOLOGY; MOTOR PERFORMANCE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD INJURY; THORAX INJURY; WHITE MATTER; WILD TYPE;

ANIMALS; ASTROCYTES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EXCITATORY AMINO ACID TRANSPORTER 2; GLIOSIS; GLUTAMIC ACID; MICE; MICE, KNOCKOUT; SPINAL CORD; SPINAL CORD INJURIES;

EID: 80053525591     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21241     Document Type: Article

References (36)

1. Agrawal SK, Fehlings MG. 1997. Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury. J Neurosci 17: 1055-1063.
2. Baptiste DC, Fehlings MG. 2006. Pharmacological approaches to repair the injured spinal cord. J Neurotrauma 23: 318-334.
3. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. 2006. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 23: 635-659.
4. Cao H, Zhang YQ. 2008. Spinal glial activation contributes to pathological pain states. Neurosci Biobehav Rev 32: 972-983.
5. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. 2004. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24: 2143-2155.
6. Gaviria M, Privat A, d'Arbigny P, Kamenka J, Haton H, Ohanna F. 2000. Neuroprotective effects of a novel NMDA antagonist, Gacyclidine, after experimental contusive spinal cord injury in adult rats Brain Res 874: 200-209.
7. Holtz A, Gerdin B. 1991. MK 801, an OBS N-methyl-D-aspartate channel blocker, does not improve the functional recovery nor spinal cord blood flow after spinal cord compression in rats. Acta Neurol Scand 84: 334-338.
8. Hulsebosch CE. 2008. Gliopathy ensures persistent inflammation and chronic pain after spinal cord injury. Exp Neurol 214: 6-9.
9. Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, Rothstein JD, Maragakis NJ. 2008. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 11: 1294-1301.
10. Lepore AC, O'Donnell J, Bonner JF, Paul C, Miller ME, Rauck B, Kushner RA, Rothstein JD, Fischer I, Maragakis NJ. 2011. Spatial and temporal changes in promoter activity of the astrocyte glutamate transporter GLT1 following traumatic spinal cord injury. J Neurosci Res 89: 1001-1017.
11. Li S, Mealing GA, Morley P, Stys PK. 1999. Novel injury mechanism in anoxia and trauma of spinal cord white matter: Glutamate release via reverse Na+-dependent glutamate transport. J Neurosci 19: RC16.
12. Liu D, Thangnipon W, McAdoo DJ. 1991. Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res 547: 344-348.
13. Liu S, Ruenes GL, Yezierski RP. 1997. NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord. Brain Res 756: 160-167.
14. Maragakis NJ, Rothstein JD. 2004. Glutamate transporters: Animal models to neurologic disease. Neurobiol Dis 15: 461-473.
15. McAdoo DJ, Xu G, Robak G, Hughes MG, Price EM. 2000. Evidence that reversed glutamate uptake contributes significantly to glutamate release following experimental injury to the rat spinal cord. Brain Res 865: 283-285.
16. McDonald JW, Becker D. 2003. Spinal cord injury: Promising interventions and realistic goals. Am J Phys Med Rehabil 82( 10 Suppl): S38-S49.
17. Mitani A, Tanaka K. 2003. Functional changes of glial glutamate transporter GLT-1 during ischemia: An in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J Neurosci 23: 7176-7182.
18. Mu X, Azbill RD, Springer JE. 2002. NBQX treatment improves mitochondrial function and reduces oxidative events after spinal cord injury. J Neurotrauma 19: 917-927.
19. Norenberg MD, Smith J, Marcillo A. 2004. The pathology of human spinal cord injury: Defining the problems. J Neurotrauma 21: 429-440.
20. Okano H, Ogawa Y, Nakamura M, Kaneko S, Iwanami A, Toyama Y. 2003. Transplantation of neural stem cells into the spinal cord after injury. Semin Cell Dev Biol 14: 191-198.
21. Olsen ML, Campbell SC, McFerrin MB, Floyd CL, Sontheimer H. 2010. Spinal cord injury causes a wide-spread, persistent loss of Kir4.1 and glutamate transporter 1: Benefit of 17 beta-oestradiol treatment. Brain 133: 1013-1025.
22. Panter SS, Yum SW, Faden AI. 1990. Alteration in extracellular amino acids after traumatic spinal cord injury. Ann Neurol 27: 96-99.
23. Pardo AC, Wong V, Benson LM, Dykes M, Tanaka K, Rothstein JD, Maragakis NJ. 2006. Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice. Exp Neurol 201: 120-130
24. Park E, Velumian AA, Fehlings MG. 2004. The role of excitotoxicity in secondary mechanisms of spinal cord injury: A review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21: 754-774.
25. Paul C, Samdani AF, Betz RR, Fischer I, Neuhuber B. 2009. Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods. Spine 34: 328-334.
26. Plemel JR, Duncan G, Chen KW, Shannon C, Park S, Sparling JS, Tetzlaff W. 2008. A graded forceps crush spinal cord injury model in mice. J Neurotrauma 25: 350-370.
27. Rosenberg LJ, Teng YD, Wrathall JR. 1999. 2, 3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion. J Neurosci 19: 464-475.
28. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, et al. 2005. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433: 73-77.
29. Sofroniew MV. 2009. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32: 638-647.
30. Stys PK. 2004. White matter injury mechanisms. Curr Mol Med 4: 113-130.
31. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T, et al. 1997. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276: 1699-1702.
32. Vera-Portocarrero LP, Mills CD, Ye Z, Fullwood SD, McAdoo DJ, Hulsebosch CE, Westlund KN. 2002. Rapid changes in expression of glutamate transporters after spinal cord injury. Brain Res 927: 104-110.
33. Wrathall JR, Choiniere D, Teng YD. 1994. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J Neurosci 14(11 Pt 1): 6598-6607.
34. Xu GY, Hughes MG, Ye Z, Hulsebosch CE, McAdoo DJ. 2004. Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord. Exp Neurol 187: 329-336.
35. Xu GY, Hughes MG, Zhang L, Cain L, McAdoo DJ. 2005. Administration of glutamate into the spinal cord at extracellular concentrations reached postinjury causes functional impairments. Neurosci Lett 384: 271-276.
36. Yi JH, Hazell AS. 2006. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem Int 48: 394-403.